Cullinan Oncology Inc.

AI Score

0

Unlock

10.01
-1.03 (-9.33%)
At close: Jan 14, 2025, 3:59 PM
10.05
0.39%
Pre-market Jan 15, 2025, 08:30 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -153.16M 109.19M -67.48M -59.46M -21.65M -14.19M
Depreciation & Amortization 310.00K 93.00K 53.00K 62.00K 70.00K 43.00K
Stock-Based Compensation 30.44M 27.96M 24.38M 14.91M 17.00K n/a
Other Working Capital -172.00K 11.69M 1.29M 1.27M -504.00K 120.00K
Other Non-Cash Items -11.52M -275.08M 67.00K 7.63M 539.00K 252.00K
Deferred Income Tax n/a n/a 3.10M 233.00K -4.00K n/a
Change in Working Capital -339.00K 11.18M -3.54M 6.85M 135.00K 345.00K
Operating Cash Flow -134.28M -126.66M -43.43M -29.77M -20.90M -13.55M
Capital Expenditures -208.00K -1.13M -589.23K -10.00K -20.00K -261.00K
Acquisitions -36.01K 275.00M 923.00K 1.45M n/a n/a
Purchase of Investments -373.38M -377.92M -525.81M -69.76M -35.38M n/a
Sales Maturities Of Investments 409.40M 352.93M 192.04M 62.90M n/a n/a
Other Investing Acitivies 36.01K 91.00K -333.77K -5.41K -35.38K n/a
Investing Cash Flow 35.81M 248.97M -333.77M -5.42M -35.40M -261.00K
Debt Repayment 1.82M -2.20M n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a -378.00K n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 538.00K -23.73M 1.52M 138.88M 85.72M -30.00K
Financial Cash Flow 40.75M -25.93M 268.78M 140.14M 85.72M -29.00K
Net Cash Flow -57.72M 96.38M -108.42M 104.95M 29.42M -13.84M
Free Cash Flow -134.48M -127.80M -44.02M -29.78M -20.92M -13.81M